We also provided evidence that AST/ALT ≥ 1.38 was significantly associated with more severe chest CT findings, worse laboratory results, higher severity of illness scores, and poor prognosis as an independent risk factor of COVID-19 patients. The gene discussed is GPT; the disease is COVID-19.